Selective HDAC6 inhibition protects against blood-brain barrier dysfunction after intracerebral hemorrhage

CONCLUSIONS: Inhibition of HDAC6 expression showed beneficial effects against BBB disruption after experimental ICH, which suggested that HDAC6 could be a novel and promising target for ICH treatment.PMID:37665135 | DOI:10.1111/cns.14429
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Source Type: research